Search This Blog

Friday, June 30, 2023

Reanlytix: Marketing Authorization to Assess Kidney Function Decline in Diabetes, Kidney Disease

 Simple Blood Test Aids Risk Assessment for Approximately 14 Million Eligible Patients in the United States

Diabetic Kidney Disease is the Leading Cause of End Stage Kidney Disease in the United States

https://finance.yahoo.com/news/fda-grants-novo-marketing-authorization-220100223.html

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.